Fig. 1From: Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapyDecision-analytic model for cost-utility analysis. The decision tree shows the four possible health states that a model patient can experience after receiving an antiemetic regimen. Olanzapine-containing regimen comprised dexamethasone, palonosetron, aprepitant, and olanzapineBack to article page